OncoSec Medical Inc (ONCSQ)

[$Moneypenny$]

Just got off the phone with Patrick. This was the substance of our conversation:

1. I mentioned to him that it is irritating that events will be in the public domain such as today's conference and ONCS has not PR'd the fact that they are either participating/sponsoring, etc. until 2-3 days before the conference. My suggestion was to issue a PR at the end of each month outlining what events are coming up in the following month and then issue a more detailed PR 2-3 days before the conference. I told him that I think this approach would lessen the phone calls/e-mails/complaints that investors have because news would be released in a consistent way. He agreed completely and is taking this suggestion to the powers at be. I don't him at the very least, they could send out a newsletter to shareholders about the events in the following month and then PR the event 2-3 days before.

2. I asked about the goals laid out in the 2014 strategic update and he said that they are hitting all of their goals and have added some throughout this year.

3. I asked about the catalysts for the rest of the year. He said that the second half of the year is stacked with catalysts and that in his opinion will add significant shareholder value.

4. I asked about the new indication trial. He wouldn't comment on which indication is was but said the natural choice would be breast or head and neck. He did say though that the trial parameters are already set, it is funded with and has the infrastructure already in place.

5. I asked about future studies coming out of Old Dominion with Dr. Heller. He said that yes that the research agreement is still alive and well and to expect future releases.

6. I asked about the R & D in Seattle and San Diego. He just said that they had a slew of research going on right now and that their goal is to be the premier intra-tumorial company in the world.

7. I asked about the P2B trial and he said that ONCS is right on schedule for the start of that trial. Of course, he wouldn't and couldn't comment on any potential partnership etc.

8. He said several times that he really thought that ONCS data and plan going forward would work and he was excited about the prospects.

Just an overall pleasant conversation with the overall presentation that ONCS is doing something really special.